Child undernutrition, a form of malnutrition, is a major public health burden in developing countries. Supplementation interventions targeting the major micronutrient deficiencies have only reduced the burden of child undernutrition to a certain extent, indicating that there are other underlying determinants that need to be addressed. Aflatoxin exposure, which is also highly prevalent in developing countries, may be considered an aggravating factor for child undernutrition. Increasing evidence suggests that aflatoxin exposure can occur in any stage of life, including in utero through a trans-placental pathway and in early childhood (through contaminated weaning food and family food). Early life exposure to aflatoxin is associated with adverse effects on low birth weight, stunting, immune suppression, and the liver function damage. The mechanisms underlying impaired growth and aflatoxin exposure are still unclear but intestinal function damage, reduced immune function, and alteration in the insulin-like growth factor axis caused by the liver damage are the suggested hypotheses. Given the fact that both aflatoxin and child undernutrition are common in sub-Saharan Africa, effective interventions aimed at reducing undernutrition cannot be satisfactorily achieved until the interactive relationship between aflatoxin and child undernutrition is clearly understood, and an aflatoxin mitigation strategy takes effect in those vulnerable mothers and children.
Introduction
Malnutrition includes both overweight, which occurs when particular nutrients are over consumed, and undernutrition, which occurs when there is inadequate energy and/or nutrient intake, poor nutrient absorption, or nutrient loss due to infection . Undernutrition, including stunting and wasting, as well as micronutrient deficiencies, is a major public health problem for low-income countries, specifically among young children (Black et al., 2013) . The short-and long-term health consequences of child undernutrition can be severe and irreversible and include impaired cognitive development, increased vulnerability to infectious diseases, and reduced educational outcomes and economic productivity in adulthood (Black et al., 2013) . Furthermore, undernutrition is responsible for approximately 3.1 million child deaths each year, with 45% of all child deaths in 2011 having been attributed to this cause (Black et al., 2013) .
It is recognized that there is a window of opportunity for reducing the burden and the lasting impact of child undernutrition, in particular impaired growth. This critical period is defined as the first 1000 days of life from conception to 24 months of age (Shrimpton et al., 2001; Victora et al., 2010) . Bhutta et al. (2008) reviewed the potential effect on child undernutrition outcomes of nutrition-specific interventions such as breastfeeding promotion, micronutrient supplementation, and diversified complementary feeding during this critical period and up to 36 months in the 36 countries with the highest burden of child stunting. By modeling the survival and linear growth status of the annual birth cohort from birth to 36 months, these authors concluded that existing interventions could potentially reduce stunting at 36 months by 36%; mortality by 25% (from birth to 36 months); and stunting, wasting, fetal growth restriction, and micronutrient deficiencies disability-adjusted life years by approximately 25%. Although these outcomes are encouraging, causes of undernutrition are multifactorial and are not solely related to dietary intake. Nutrition-specific interventions address the immediate determinants of child undernutrition, such as inadequate food and nutrient intake, but do not consider the underlying causes such as food insecurity, poverty, and limited access to clean water, hygienic environments, and health services (Black et al., 2013; Ruel et al., 2013) .
There is increasing evidence that exposure to aflatoxin could be an underlying factor of child undernutrition. Aflatoxin is a mycotoxin produced by Aspergillus flavus and Aspergillus parasiticus that contaminates staple crops in many of the countries where child stunting is also prevalent. Although Aspergillus molds occur in soil across a wide geographic distribution, hot and humid conditions are favorable for aflatoxin production, with stress to crops caused by drought conditions promoting the contamination of susceptible crops (such as maize and groundnuts) in the field (Pitt et al., 2013) . Further growth of the fungus and production of aflatoxin is enhanced by postharvest storage conditions that involve high humidity (Mutegi et al., 2013) . There are four main types of aflatoxin, namely aflatoxin B 1 (AFB 1 ), aflatoxin B 2 (AFB 2 ), aflatoxin G 1 (AFG 1 ), and aflatoxin G 2 (AFG 2 ). AFB 1 is the most potent toxin and is the most prevalent one, accounting for an average of 70% of the total aflatoxin content in food, although this may vary depending on the strain of the fungus and local conditions. Aflatoxin M 1 (AFM 1 ) is a toxic metabolite of AFB 1 , which can be found in milk of lactating mothers, and milk and meat of animals exposed to aflatoxin.
Human exposure to contaminated food is highest in countries with high consumption of susceptible staple crops grown and stored under optimal fungal growth conditions. Aflatoxin exposure often causes acute outbreaks and sometimes fatal liver toxicity (Azziz-Baumgartner et al., 2005) . Chronic exposure can increase the risk of liver cancer (International Agency for Research on Cancer (IARC), 2002), in particular through an interaction with the hepatitis B virus. There is increasing evidence that aflatoxin plays a role in other health effects such as hepatomegaly (Gong et al., 2012) , immune suppression Jiang et al., 2005 Jiang et al., , 2008 and growth faltering in children (Gong et al., 2002 (Gong et al., , 2004 . Chronic aflatoxin exposure is evident throughout life, including the critical first 1000 days (Wild and Gong, 2010) .
With the increasing evidence that aflatoxin can exacerbate the effects of undernutrition and contribute to growth faltering, it is likely that aflatoxin exposure has inhibited the expected growth improvement predicted for nutritional intervention programs. In this review, we will summarize the burden of childhood undernutrition and the current achievement of nutrition-specific interventions for improving child growth, review the evidence for aflatoxin exposure exacerbating undernutrition, and reflect on the necessity for considering aflatoxin exposure in nutrition intervention programs.
Child undernutrition and nutrition-specific interventions in the developing world
Protein energy malnutrition Protein energy malnutrition (PEM), considered to be the leading form of childhood malnutrition in developing countries, includes the disorders kwashiorkor, marasmus, and marasmus-kwashiorkor, which are differentiated by the balance between inadequate protein intake and other energy sources (Ahmed et al., 2012) . PEM is often a consequence of inadequate food intake; lack of diet diversity; consuming a diet of poor protein quality, typically cereal-based and low in animal products; suboptimal breastfeeding; delayed and/or inadequate supplementation of appropriate complementary foods, and infection that can lead to decreased absorption of essential nutrients (Latham, 1997) .
In 2000, the World Health Organization (WHO) (2002) estimated that 26.7% of children aged less than five years in developing countries had PEM. There is a paucity of recently conducted population-based studies that have investigated the prevalence of different types of PEM in developing countries. Kwashiorkor, edematous malnutrition, has been included within the estimates for the prevalence of, and deaths attributable to, severe acute malnutrition (SAM) (weight-for-height Z score (WHZ) below ¡3, according to World health Organization Working Group (1986) standards). In 2011, the global prevalence of SAM in children aged less than five years was 3% (19 million) with higher percentages observed in central Africa (5.6%) and south-central Asia (5.1%) (Black et al., 2013) .
A recent systematic review evaluated the effectiveness of inpatient management for SAM using the WHO protocol, as well as community-based treatments in low-and middle-income settings, focusing on the children aged less than five years (Lenters et al., 2013) . The authors found that case fatality rates for inpatient management of SAM, following the WHO protocol, which involves treating infections, fluid management, and micronutrient supplementation, ranged from 3.4% to 35%. Only two studies reported nutrition recovery rates, which were 79.7% and 83.3%. For the community-based treatment of SAM that involves the use of ready-to-use therapeutic food (RUTF), 51% of children were more likely to achieve nutritional recovery than a standard care group. Although this systematic review was limited in the availability of high quality studies, the nutritional recovery rates of the interventions reviewed were advantageous. The authors have concluded that future studies are warranted to compare approaches to managing SAM, and this includes identifying and tackling other aggravating determinants of SAM.
Growth faltering
Stunting (height-for-age Z score (HAZ) < ¡2), wasting (WHZ < ¡2), and underweight (weight-for-age Z score (WAZ) < ¡2, according to WHO standards) (World health Organization Working Group, 1986) are major indicators of child undernutrition. Severe undernutrition is considered when Z scores are < ¡3. In 2011, approximately 165 million (25.7%) children aged less than five years globally had stunted growth, 52 million (8%) were classified as wasting and 100 million (16%) were underweight (UNICEF, WHO and World Bank, 2012) . South-central Asia (36% stunted, 15% wasting, and 30% underweight) as well as East (42% stunted) and West Africa (36% stunted and 22% underweight) had the highest prevalence. Growth faltering in early life is a predisposing risk factor for poor cognitive development, reduced educational outcomes and economic productivity as well as reduced survival in adulthood (Black et al., 2013) . Micronutrient deficiencies alongside recurring infections are some of the well-recognized causes of child growth faltering in developing countries. There are three micronutrient deficiencies of public health concern in developing countries: vitamin A, iron, and zinc deficiency (ZD). Interventions (supplementation) targeting these specific micronutrient deficiencies and their impact on growth outcomes are summarized in Table 1 .
Zinc deficiency
A recent analysis conducted by Wessells and Brown (2012) estimated the global prevalence of zinc deficiency as 17% in 188 countries, using zinc intake obtained from FAO food balance sheets, with zinc and phytate contents calculated using a nutrient composition database (Table 1) . Low-income countries, such as those in sub-Saharan Africa and South Asia, were most at risk with a ZD prevalence of over 25%. Zinc deficiency is primarily caused by low intake of animal products and exacerbated by persistent diarrhea (Ahmed et al., 2012; Lindenmayer et al., 2014) . Zinc deficiency can compromise aspects of immunity, thereby enhancing susceptibility to infectious diseases such as diarrhea, malaria, and pneumonia (Ahmed et al., 2012) .
It may also aggravate intestinal permeability and chronic inflammation, both pathways that underlie environmental enteropathy, which is a sub-clinical condition involving reduced intestinal function that can affect micronutrient absorption (Lindenmayer et al., 2014) . Zinc has a fundamental role in cell division and growth; thus, it can result in decreased Table 1 . Major micronutrient deficiencies of public health concern: global prevalence and regions with the highest prevalence, micronutrient supplementation, and physical growth outcomes in children.
Micronutrient Prevalence
Micronutrient supplementation on growth. Evidence from systematic reviews and meta-analyses Thickness or head circumference Iron supplementation for 2 months to 12 months Low et al., 2013 No significant effect on absolute height, absolute weight, or WHZ Meta-analysis of RCTs A positive effect on HAZ (mean difference D 0.09; 95% CI: 0.01-0.17) Children aged 5 to 12 years
In comparison with control subjects Oral iron supplementation 5 days per week Pasricha et al., 2013 No significant effect on final weight, WAZ, final length, or LAZ Meta-analysis of RCTs Children randomized to iron supplementation groups had lesser Children aged 4-23 months Length (SMD: ¡0¢83, 95% CI: ¡1¢53 to ¡0¢12) and weight gain Daily oral iron supplementation (SMD: ¡1.12, 95% CI: ¡1.19 to ¡0.33) in comparison with control subjects Thompson et al., 2013 No positive effect on physical growth Meta-analysis of RCTs Children aged 2 to 5 years Oral iron supplementation for 5 concentrations of circulatory Insulin-like Growth Factor 1 (IGF-1), a possible pathway for slowed child growth in zinc deficiency children (Prasad, 2013) . Zinc deficiency in developing countries coincides with the high prevalence of stunted growth in children observed in these countries (Wessells and Brown, 2012) . In fact, assessing the number of children aged less than five years having stunted growth has been considered to be a proxy for zinc deficiency (de Benoist et al., 2007; Wessells and Brown, 2012) , although this is an indirect method for measuring zinc deficiency, and consequently is subjected to confounding factors. It would be expected, therefore, that zinc supplementation would have a positive effect on growth. Four metaanalyses (Brown et al., 2002 (Brown et al., , 2009 Ramakrishnan et al., 2009; Imdad and Bhutta, 2011) have been identified that have investigated the impact of zinc supplementation on growth indices in childhood (Table 1) . Three meta-analyses found that zinc supplementation had a significant positive effect on linear growth (Brown et al., 2002 (Brown et al., , 2009 Imdad and Bhutta, 2011) , and two found that it had a positive effect on weight gain (Brown et al., 2002 (Brown et al., , 2009 . In contrast, Ramakrishnan et al. (2009) found no effect of zinc supplementation on linear growth or weight change but did find a significant positive effect on change in WHZ score. Although it is apparent from the aforementioned evidence that zinc can have a positive impact on growth, it is important to highlight that its effect is only marginal.
Iron deficiency
Iron deficiency (ID) is the leading cause of anemia (hemoglobin < 110 g/L) and accounts for »50% of all cases (UNICEF, UNU and WHO, 2001) . For this reason anemia is typically used as a proxy for iron deficiency. Stevens et al. (2013) estimated the global prevalence of total and severe anemia in three population groups known to be most vulnerable to the following conditions: women of child bearing age (15-49 years), children (6-59 months), and pregnant women. Using representative population-based data collected from 107 countries, it was evident that anemia is in epidemic proportions worldwide (Table 1) . Regional analysis showed Central and West Africa as having the highest prevalence of anemia and severe anemia in children aged less than five years in 1995 (80% and 9.7% respectively) and 2011 (71% and 4.9% respectively). The high prevalence observed in the developing parts of the world is most likely due to diets low in iron rich foods alongside poor absorption and diets high in phytate compounds that inhibit iron absorption (Zimmermann and Hurrell, 2007) . Parasite infections as well as tuberculosis and HIV are also thought to be the risk factors.
Poor growth and cognitive development during childhood have been suggested as major consequences of iron deficiency, although the evidence supporting these suggestions is inconclusive. For example, several systematic reviews and meta-analyses of randomized controlled trials (RCTs) have failed to discover a positive effect of iron supplementation on different growth parameters in children (Table 1) (Ramakrishnan et al., 2004; Sachdev et al., 2006; Pasricha et al., 2013; Thompson et al., 2013) . However, a recent systematic review and meta-analysis (Low et al., 2013) found a small positive effect on growth (HAZ) in children that were aged between 5 and 12 years. Similarly, systematic reviews have reported that iron supplementation can have an impact on cognitive development, especially in older children (Sachdev et al., 2005; Low et al., 2013) but appears to be ineffectual in young children and infants (Sachdev et al., 2005; Szajewska et al., 2010; Pasricha et al., 2013; Thompson et al., 2013) . This evidence indicates that iron supplementation may have more of an impact on growth performance and cognitive development during mid-childhood. Of course, this may challenge the view that interventions targeting growth should occur in the first 1000 days of life (Shrimpton et al., 2001; Victoria et al., 2010) , as beyond this timeframe interventions are considered to be ineffectual. Nevertheless, it is noted that the positive effect on growth reported in these studies (Low et al., 2013) was only marginal, indicating that iron supplementation targeting mid-childhood may only have limited success as a public health intervention.
Vitamin A deficiency
According to a WHO (2009) report, vitamin A deficiency (VAD), defined as having serum (plasma) retinol concentrations less than 0.70 mmol/L or having a history of night blindness in more severe cases, is considered to be a major public health problem in developing countries, specifically in Asia and sub-Saharan Africa. In that report, the global prevalence of VAD measured between 1995 and 2005 in pregnant women was 15.3% and when stratified according to WHO regions, Africa and Asia had the highest rates (14.3 and 18.4%). This trend was also observed in children aged less than five years. Global prevalence was 33.3%, with Africa (41.6%) and Asia (33.5%) having higher rates than other parts of the world.
The developing fetus and preschool aged children are considered as at-risk populations because of rapid growth and subsequent increased nutritional requirements during these stages of the life course. In developing countries, these additional nutritional requirements are frequently not met due to the lack of diet diversity as well as the affordability of foods high in vitamin A such as animal products and dark green vegetables. Over the past decade, some observational studies have found that maternal VAD was associated with lower birth weight (Gazala et al., 2003; Tielsch et al., 2008) . In contrast, according to a recent systematic review and meta-analysis, vitamin A supplementation during pregnancy had no positive effect on birth weight (Thorne-Lyman and Fawzi, 2012). Furthermore, vitamin A supplementation during childhood showed little or no effect on growth in several RCTs (Rivera et al., 2003; Rmakrishnan et al., 2004; Mahawithange et al., 2007; Chhagan et al., 2010; Lima et al., 2010) .
It is clear from the above evidence that supplementation interventions targeting the main micronutrients of public health concern in developing countries are not entirely effective in improving child growth. Vitamin A supplementation markedly has no impact on child growth, whereas zinc and iron supplementation seem to have peripheral effects. This suggests that there are other underlying determinants of child growth faltering that need to be addressed.
Aflatoxin-related undernutrition issues in the developing world
Aflatoxin exposure and its relationship with growth faltering The development and application of the aflatoxin-albumin adduct (AF-alb) biomarker has enabled a number of epidemiology studies examining human health effects of aflatoxin exposure (Routledge and Gong, 2011) . This biomarker, which is usually measured by an ELISA method (Chapot and Wild, 1991) , has shown a good correlation with aflatoxin intake in adults through a groundnut-based diet in The Gambia (Wild et al., 1992) as well as in children through a maize-based weaning diet in Tanzania . Compared with other available short-term (for previous 1-2 days exposure) biomarkers such as the aflatoxin DNA adduct, AFM 1 , and aflatoxin metabolites in urine, this biomarker reflects the previous 2-3 months exposure at the individual level, and is therefore more appropriate for assessing chronic exposure-related health outcomes.
There is a mounting evidence that aflatoxin exposure occurs from gestation onwards throughout life (Wild and Gong, 2010; Khlangwiset et al., 2011) . Exposure occurs in utero through the transfer of aflatoxins from the mother to the fetus via placenta. Several studies have investigated this route of exposure and have found detectable concentrations of aflatoxin or AF-alb in cord blood samples Dennings et al., 1990; Wild et al., 1991; Jonsyn et al., 1995; Turner et al., 2007) . Only a few studies have examined the impact of exposure in utero on birth weight Abdulrazzaq et al., 2004; Shuaib et al., 2010) . All have reported a significant inverse relationship with higher exposure in utero corresponding to lower weight at birth. A study by de Vries et al. (1989) conducted in rural Kenya examined aflatoxin concentrations in maternal and cord blood samples. Aflatoxin was detected in over half of the maternal samples and 37% of the cord blood samples. Females born to aflatoxin positive mothers had a mean birth weight that was 225 g lower than those born to mothers free from aflatoxin exposure. Similar results were observed in a study conducted in the Middle East by Abdulrazzaq et al., (2004) , where high aflatoxin concentrations in maternal and cord blood samples were significantly related to lower birth weights (r D ¡0.654, P < 0.0001, and r D ¡0.565, P < 0.001, respectively). More recently, a cross-sectional study of 785 pregnant Ghanaian women, after adjusting for socio-demographic variables and other factors, found increased odds of delivering a baby with a low birth weight in the highest quartile (Shuaib et al., 2010) . The highest quartile represented the highest concentrations of aflatoxin exposure measured in blood during pregnancy (odds ratio (OR): 2.09; 95% confidence interval (CI): 1.19-3.68).
Aflatoxin exposure in utero may also play a role in stunted growth in early childhood. Only one study to date has explored this temporal relationship (Turner et al., 2007) , and found that higher concentrations of AF-alb in maternal blood were significantly associated with lower WAZ (¡0.25; P D 0.012) and HAZ (¡0.21; P D 0.044) measurements after adjusting for potential confounding factors. Furthermore, the authors predicted that a reduction in maternal AF-alb concentration from 110 to 10 pg/mg would lead to a 2-cm increase in height and a 0.8-kg increase in weight within the first 12 months of life.
Usually studies that have examined exposure in utero by measuring maternal blood only obtained measurements at one point in time. A recent study conducted by Castelino et al., (2014) explored the effect of season and gestation stage on aflatoxin exposure in pregnant women from The Gambia. Results showed that mean AF-alb concentrations were higher during the dry season than the rainy season. AF-alb concentrations increased marginally from early to later gestation (34.5 pg/mg vs. 41.8 pg/mg; P < 0.05). Although early pregnancy has been considered a period when the fetus is most vulnerable, later pregnancy marks the fast growth period of the fetus, which may exert a profound adverse impact on growth. Further research is warranted to determine the longer-term health effects of aflatoxin exposure during both early and late pregnancy.
Weaning is the transition from breast milk to solid food, and normally begins between 3 and 6 months. It is often a period in developing countries when children are most susceptible to PEM. Since weaning foods such as maize are prone to aflatoxin contamination, there may also be high aflatoxin exposure during the weaning period. This was evident in a study conducted by Gong et al. (2003) in Benin and Togo, as children that were fully weaned had approximately two-fold higher mean AF-alb concentrations than children who were still partially breastfed. Although breastfeeding is a period of lower aflatoxin exposure, there is still some exposure from breast milk, with AFM 1 having been found in breast milk samples in many studies (Khlangwiset et al., 2011) . AFM 1 , a hydroxylated metabolite of aflatoxin, has hepatotoxic and hepatocarcinogenic potential, and is recognized by the International Agency for Research on Cancer as a possible human carcinogen (Group 2B) (IARC, 2002) . There is limited information, however, regarding the adverse health effects of AFM 1 in humans, especially in exclusively breast-fed children (IARC, 2002) . Nevertheless, exclusive breastfeeding up to six months should still be encouraged, as AFM 1 found in milk is less toxic and occurs at lower levels than AFB 1 found in food. Furthermore, breast milk is abundant in immunological and nutritional components (Thibeau and D'Apolito, 2012) , which are essential for proper growth and development.
The impact of aflatoxin exposure on growth is considered most prominent during the first two years of birth. One of the first studies examining the association between aflatoxin exposure and child growth performance was a cross-sectional study of 480 children from Benin and Togo aged between nine months and five years (Gong et al., 2002) . Prevalence of aflatoxin was high in this sample with 99% of the children having detectable concentrations and a reported geometric mean of 32.8 pg/mg. Undernutrition was also evident as 33, 6, and 29% of the children were classified as having stunted growth (HAZ < ¡2), wasting (WHZ < ¡2), and being underweight (WAZ < ¡2) respectively. Significant negative correlations between AF-alb and each of the growth parameters were observed (P D 0.001 for stunting; P D 0.047 for wasting; and P D 0.005 for underweight). Another cross-sectional study of 472 Gambian children aged between six and nine years found that AF-alb concentrations were weakly associated with wasting (P D 0.034) but not with stunting or underweight.
These earlier studies were the first in determining the association of aflatoxin dietary exposure with growth impairment in human subjects, and generated hypotheses for further investigations. Cross-sectional studies are the best way to measure prevalence (Mann, 2003) ; however, they do have limitations, as they cannot be used to establish the temporal sequence of the relationship observed. A subsequent study using a longitudinal design examined the effects of aflatoxin exposure on growth in a cohort of 200 children from Benin (aged 16-37 months) followed up for over eight months (Gong et al., 2004) . High prevalence of aflatoxin exposure was found across the cohort with almost all samples being positive for aflatoxin at each time point and with mean AF-alb concentrations of 37.4 pg/mg (February), 38.7 pg/mg (June) and 86.8 pg/mg (October). Results showed that both AF-alb concentrations measured in February and the mean AF-alb concentration from the three time points were inversely correlated with HAZ and WHZ growth parameters that were measured at the end of the study. This relationship remained after adjusting for potential confounding factors such age, sex, height, weaning status, socioeconomic status (SES), and geographical location, although only for the HAZ growth parameter (P < 0.001). Furthermore, there was a difference of 1.7 cm in height between the highest and the lowest AF-alb quartile over the eight-month period. This study has helped to show the temporal relationship between aflatoxin exposure and impaired child growth. Although additional longitudinal studies conducted in different geographical locations and populations will strengthen the evidence on the likelihood of this effect being cause and effect. Furthermore, plausible mechanisms that link aflatoxin exposure with impaired child growth should be investigated.
Aflatoxin exposure and protein energy malnutrition
It has been proposed that the development of kwashiorkor may be partly attributable to aflatoxin exposure, although the evidence is circumstantial. Both aflatoxin exposure and kwashiorkor are prevalent in hot and humid tropical countries where maize and rice are staples, both affect children in early life, and both are associated with impaired child growth (Hendrickse, 1997; Wild and Gong, 2010) . Furthermore, they have similar clinical and metabolic characteristics, such as fatty liver and immunosuppression .
As shown in Table 2 , the association between the exposure to aflatoxin and kwashiorkor has been investigated in a plethora of studies since the 1980s Lamplugh and Hendrickse, 1982; Apeagyei et al., 1986; Coulter et al., 1986; de Vries et al., 1987 de Vries et al., , 1990 Househam and Hundt, 1991; Ramjee et al., 1992; Adhikari et al., 1994; Oyelami et al., 1997 Oyelami et al., , 1998 Hatem et al., 2005; Tchana et al., 2010; Onyemelukwe et al., 2012) . The typical study designs employed by the majority of these studies were case-control or crosssectional, and involved measuring the prevalence and concentration of aflatoxin in blood and urine samples. Some studies found that aflatoxin was detected more frequently or concentrations were higher in blood samples of children with kwashiorkor in comparison with children with marasmus and healthy children Coulter et al., 1986; de Vries et al., 1987; Hatem et al., 2005; Onyemelukwe et al., 2012) . Furthermore, it has been suggested that children with kwashiorkor have an inability to metabolize aflatoxin, as in conjunction with the high concentrations found in serum, excretion of aflatoxin seems to occur at a lesser and slower rate (Ramajee et al., 1992) . This is likely due to the impaired function of the liver; a clinical manifestation of this protein malnutrition disorder (Ramjee et al., 1992) . Adhikari et al. (1994) proposed that this retention of aflatoxin may also help explain the increased number of infections observed in aflatoxin-positive children with kwashiorkor from Durban, South Africa, compared to aflatoxin-negative children with kwashiorkor.
Autopsies have also been conducted on the liver Apeagyei et al., 1986) , lung (Oyelami et al., 1997) , and kidney (Oyelami et al., 1998) specimens of African children who died as a result of PEM. Aflatoxin was detected more often in the liver specimens from children who had died from kwashiorkor compared to other diseases and other protein malnutrition disorders (Lamplugh and Hendrickse, 1984) .
Although evidence suggests that aflatoxin exposure may be related to kwashiorkor prevalence, a causal relationship has not been established. Furthermore, most of the studies did not measure AF-alb concentrations in serum of exposed children, which has been shown to be a more reliable biomarker. A fundamental step in unraveling any link between aflatoxin and kwashiorkor is to understand the possibility that the metabolic manifestations of kwashiorkor affect the way that aflatoxins are metabolize and excreted from the body and vice versa. Future studies undertaking a longitudinal design are required to determine whether aflatoxin exposure plays an etiological role in the causation of kwashiorkor.
Aflatoxin exposure and micronutrient deficiencies It has been hypothesized that aflatoxin exposure mediates intestinal damage, resulting in reduced nutrient absorption and increased intestinal permeability resulting in faltered growth (Gong et al., 2008; Smith et al., 2012) . It is, therefore, possible that aflatoxin exposure exacerbates micronutrient deficiencies, and by reducing aflatoxin exposure, the incidence of micronutrient deficiencies may be reduced correspondingly. Previous research has established the relationship between aflatoxin exposure and the effect on these micronutrients in feeding experiments in animal studies as reviewed by Williams et al., (2004) . Increasing concentrations of aflatoxin in feed were significantly related to decreasing concentrations of vitamin A in poultry (Pimpukdee et al., 2004) ; vitamin D concentrations in chickens (Glahn et al., 1991) ; vitamins A and E concentrations in swine (Harvey et al., 1994) as well as zinc in piglets (Mocchegiani et al., 1998) .
Owing to difference in species, it is difficult to apply directly these findings to humans. Only a few studies have been identified that have examined the relationship between micronutrient concentrations and aflatoxin exposure in human subjects Gong et al., 2004; Tang et al., 2009; Obuseh et al., 2011) . All the studies were conducted in West Africa. Two studies found no association between vitamin A and AFalb concentrations in children Gong et al., 2004) , whereas two studies did find an inverse relationship in adult subjects (Tang et al., 2009; Obuseh et al., 2011) ; higher aflatoxin exposure was correlated with lower vitamin A concentration. Aflatoxin exposure was inversely correlated with vitamin C and vitamin E (Tang et al., 2009) concentrations, but was not correlated with zinc (Gong et al., 2004) .
It is very difficult to draw specific conclusions based on the above evidence. First, only a small number of studies AM controls (n D 10) (mean age:
15.9 months) AM controls (0) AM controls (0) Aflatoxin was detected more frequently in the kwashiorkor group than the marasmus group (P D 0.007).
Aflatoxin was detected more frequently in the kwashiorkor group than the marasmus group (P have been identified that have examined the relationship between aflatoxin exposure and micronutrient deficiency in human subjects. Second, the temporal relationship has not yet been investigated as the above studies were cross-sectional; although Gong et al. (2004) was a longitudinal study, the micronutrients measured were only considered as potential confounding factors for the relationship between aflatoxin exposure and impaired child growth, and further explorations of these variables were not carried out. Furthermore, seasonal influences were not taken into account when assessing these correlations; both aflatoxin exposure levels and micronutrient intakes can fluctuate with season. It is consequently still unknown whether aflatoxin exposure exacerbates micronutrient deficiencies, and whether this contributes to impaired child growth, which previous researchers have advocated (Smith et al., 2012) . Future studies opting for a longitudinal or experimental (RCT) design are warranted to help establish whether there exists a temporal relationship.
Possible mechanisms for aflatoxin's effects on growth
It has been hypothesized that aflatoxin may affect child growth through one or more of the three mechanisms: (1) by contributing to enteropathy, (2) immune suppression, and (3) modulating the IGF pathway through liver toxicity (Gong et al., 2008; Smith et al., 2012) . Enteropathy is a frequent condition observed in babies in Africa, and may be partly attributable to aflatoxin-related toxic damage to the intestine epithelium, which leads to further "leak" of nutrients, i.e., aflatoxin exacerbates the reduction of nutrient uptake in an environment where undernutrition is already rife. The immune suppression effect of aflatoxin, for which there is a lot of evidence in animal species (Bondy and Pestka, 2000) , and increasing evidence in humans Jiang et al., 2005 Jiang et al., , 2008 could enhance susceptibility to infections such as those causing diarrhea, which would reduce nutrient uptake. Liver toxicity due to chronic aflatoxin exposure may damage the production of IGF pathway proteins in the liver, leading to reduced IGFs in circulation and an adverse impact on child growth. A recent in vitro study using human liver cells demonstrated that aflatoxin downregulated IGF genes and protein concentrations in a dose-dependent manner (Castelino et al., 2015) . In agreement with this result, both IGF1 and IGFBP3 concentrations were found to be inversely correlated with AF-alb biomarker in Kenyan schoolchildren. Although the effect of aflatoxin on IGFs only explained about 16% of the total effect of aflatoxin on child growth, given the complex causes of child stunting, the data provide preliminary evidence that aflatoxin-induced changes in IGFs could contribute to growth impairment where aflatoxin exposure is high (Castelino et al., 2015) .
Aflatoxin co-exposure with other mycotoxins on child undernutrition
Many countries in sub-Saharan Africa have a largely maizebased diet for both weaning food and family food. It has been noted that groundnuts, although often having higher incidence and concentrations of aflatoxin contamination than maize, rarely cause aflatoxicosis. Major aflatoxicosis often occurs in populations with high maize consumption. This is partly because maize is a major component of the diet and is consumed in much larger amounts than groundnuts. Another possibility is that another mycotoxin, fumonisin, often co-occurs with aflatoxin in maize in these regions (Kimanya et al., 2008 (Kimanya et al., , 2009 Shirima et al., 2013) , and it is hypothesized that the coexposure may greatly enhance aflatoxin toxicity, both acute (aflatoxicosis) and chronic, such as the childhood hepatomegaly reported in Kenya (Gong et al., 2012) .
Weaning food was found to be frequently co-contaminated with aflatoxin and fumonisin in Tanzania, and fumonisin exposure by dietary assessment has been reported to be associated with child stunting and linear growth in Tanzania (Kimanya et al., 2010) . One hundred and sixty-six children (aged 6-14 months) from representative regions in Tanzania were studied longitudinally over one year to examine exposure to both mycotoxins and its impact on child growth. AF-alb concentrations tripled during the first six months, and further doubled during the second six months, with mean concentrations of 4.7, 12.9, and 23.5 pg/mg, respectively. Fumonisin exposure measured using urinary FB 1 biomarker was exceedingly high at both maize harvest seasons but with a lower concentration observed at six months after harvest, reflecting a field mycotoxin contamination pattern . Urinary FB 1 at recruitment were negatively associated with HAZ at both six and 12 months from recruitment. Mean concentrations of urinary FB 1 had an inverse association with HAZ at 12 months from recruitment and length velocity. The negative association between AF-alb and HAZ was not significant, possibly due to study power limitation. These data show that fumonisin may contribute to child growth impairment, and highlight the potential role of co-contamination with aflatoxin and fumonisin. More recently, Srey et al. (2014) reported exposure to dietary deoxynivalenol (DON), another mycotoxin with known growth inhibition in animals, also occurs in these children, in agreement with food-based exposure analysis in Tanzania . This suggests that the children are frequently exposed to the three mycotoxins, all of which may have an impact on growth faltering. An increasing number of recent studies have reported multimycotoxin exposure in different populations, including some African groups (Abia et al., 2013; Ediage et al., 2013; Shephard et al., 2013) . The methodology applied in these studies typically involves simultaneous measurement of multiple mycotoxins using advanced liquid chromatography-mass spectrum (LC-MS)/MS technique, and this offers great advantages as it gives useful data on multi-mycotoxin exposure in a population. At present, validation of the approach when applied to health outcomes is in its infancy. It was evident from these studies that first, multiple mycotoxins coexist in staple foods such as maize and their by-products (Abia et al., 2013) , and second, human populations in Africa are co-exposed to proportionally high concentrations of multi-mycotoxins (Ediage et al., 2013; Shephard et al., 2013) . Ediage et al.'s (2013) cross-sectional study found no association between stunting, wasting, or underweight in children aged under five years, although multiple mycotoxins were found in urine samples. While the multimycotoxin measurements require further validation, these studies provide a preview of the co-exposure issue and with time more will be revealed, adding further complexity to the health risk studies. How to assess the health outcomes associated with multiple toxins will thus be a critical challenge ahead, and this will lead to a new era of development of multiple toxins exposure assessment methodology.
Conclusions
Aflatoxin exposure is highly prevalent in developing countries; often this co-exists with undernutrition, enteropathy, and infectious diseases in young children. The fact that over 90% of the samples from young children from West Africa had detectable AF-alb, in contrast to less than 1% in the developed world, clearly demonstrates a huge public health burden associated with aflatoxin in sub-Saharan Africa. The greatest challenge ahead is not only to understand how these problems may interactively impact on child stunting, but more importantly to explore the most effective intervention method for child undernutrition, and eventually to reduce child mortality. Many supplementation trials targeting the major micronutrient deficiencies aimed at improving child growth have failed to produce a significant positive effect. We believe that the high concentrations of aflatoxin exposure in these populations are likely to be exacerbating the problems posed by child undernutrition and that future nutrition interventions should consider aflatoxin exposure. The most effective outcomes are likely to be produced by an attack on two frontsreduction of aflatoxin exposure and improvement in nutritional status.
